These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25844412)

  • 21. Less abuse potential with XR formulation of quetiapine?
    Reccoppa L
    Am J Addict; 2011; 20(2):178. PubMed ID: 21314763
    [No Abstract]   [Full Text] [Related]  

  • 22. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases.
    Stamouli S; Lykouras L
    J Clin Psychopharmacol; 2006 Aug; 26(4):396-400. PubMed ID: 16855458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mania associated with quetiapine treatment].
    Cam B; Gülseren S
    Turk Psikiyatri Derg; 2014; 25(1):65-8. PubMed ID: 24590852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiologic interaction carbamazepine with atypical neuroleptics. Acute mixed carbamazepine and quetiapine intoxication--case report].
    Hydzik P; Balicka-Slusarczyk B; Jastrzebski M
    Przegl Lek; 2011; 68(8):499-502. PubMed ID: 22010449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addictive potential of quetiapine.
    Murphy D; Bailey K; Stone M; Wirshing WC
    Am J Psychiatry; 2008 Jul; 165(7):918. PubMed ID: 18593794
    [No Abstract]   [Full Text] [Related]  

  • 26. Does quetiapine have mood altering properties?
    Mishra A; Moore PB; Hobbs R
    J Psychopharmacol; 2004 Jun; 18(2):281-4. PubMed ID: 15260919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Manic symptoms probably associated with short-term low-dose quetiapine use.
    Erberk-Ozen N
    Adv Ther; 2008 Jan; 25(1):53-8. PubMed ID: 18224291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quetiapine-associated dysphagia.
    Kohen I; Lester P
    World J Biol Psychiatry; 2009; 10(4 Pt 2):623-5. PubMed ID: 18615368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quetiapine in the treatment of acute mania].
    Bräunig P
    Psychiatr Prax; 2006 Mar; 33 Suppl 1():S27-31. PubMed ID: 16511728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case report of quetiapine withdrawal syndrome in a geriatric patient.
    Kohen I; Kremen N
    World J Biol Psychiatry; 2009; 10(4 Pt 3):985-6. PubMed ID: 17965985
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting.
    Ketter TA; Brooks JO; Hoblyn JC; Holland AA; Nam JY; Culver JL; Marsh WK; Bonner JC
    J Psychiatr Res; 2010 Oct; 44(14):921-9. PubMed ID: 20378127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.
    Sattar SP; Schultz SK; Arndt S; Soundy T; Petty F
    S D Med; 2007 Nov; 60(11):437, 439-41, 443 passim. PubMed ID: 18196687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: a case series.
    Pajonk FG; Schwertner AK; Seelig MA
    J Psychopharmacol; 2006 Jan; 20(1):119-24. PubMed ID: 16204326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible withdrawal dyskinesia associated with quetiapine.
    Michaelides C; Thakore-James M; Durso R
    Mov Disord; 2005 Jun; 20(6):769-70. PubMed ID: 15747370
    [No Abstract]   [Full Text] [Related]  

  • 35. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is quetiapine a drug of abuse? Reexamining the issue of addiction.
    Tcheremissine OV
    Expert Opin Drug Saf; 2008 Nov; 7(6):739-48. PubMed ID: 18983220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose loading with extended release quetiapine.
    Chae BJ
    J Clin Pharm Ther; 2010 Aug; 35(4):487-9. PubMed ID: 20831551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ; Reimer J; Wiedemann K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use.
    Philip NS; Mello K; Carpenter LL; Tyrka AR; Price LH
    Ann Clin Psychiatry; 2008; 20(1):15-20. PubMed ID: 18297582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.